PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
Objective: To assess the outcome and complications of plasmapharesis in treatment of myasthenia gravis and factors linked to poor outcome at hematology unit of a tertiary care teaching hospital of Pakistan Study Design: Prospective comparative study. Place and Duration of Study: Pak Emirates M...
Guardado en:
Autores principales: | Maryam Abbas, Helen Mary Robert, Asad Mahmood, Saleem Ahmed Khan, Mohammad Abdul Naeem, Muhammad Ahsan Ayaz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Army Medical College Rawalpindi
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b10387d243634c198306d91e478aa9fb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fetal Surveillance in Pregnancies with Myasthenia Gravis
por: Brîndușa Ana Cimpoca-Raptis, et al.
Publicado: (2021) -
Research of antibodies to the acetylcholine receptors in patients with myasthenia gravis
por: T. V. Romanova
Publicado: (2013) -
Initial Treatment Response in Ocular Myasthenia Gravis: A Comparison Between Low and Moderate Doses of Prednisolone
por: Threetong T, et al.
Publicado: (2020) -
Miastenia gravis refractaria con buena respuesta a rituximab. Caso clínico
por: Suárez H.,Felipe, et al.
Publicado: (2020) -
Magnetic resonance imaging characteristics of thymoma in Vietnamese patients with myasthenia gravis in relation to histopathological type and disease staging
por: Phung Anh Tuan, et al.
Publicado: (2020)